Related Experiment Video
Updated: Apr 22, 2026

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Published on: May 20, 2020
Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
1Medical Oncology, British Columbia Cancer Agency - Vancouver Centre , Vancouver, BC , Canada.
Abstract:
A number of developments have altered the treatment paradigm for metastatic non-small cell, non-squamous lung cancer. These include increasing knowledge of molecular signal pathways, as well as the outcomes of several large-scale trials. As a result, treatments are becoming more efficacious and more personalized, and are changing the management and prognosis of non-small cell lung cancer patients. This is resulting in increased survival in select patient groups. In this paper, a simplified algorithm for treating patients with metastatic non-small cell, non-squamous lung cancer is presented.
Insights
New treatments for metastatic non-squamous non-small cell lung cancer offer personalized care and improved survival. This paper presents a simplified treatment algorithm for these patients.
Area of Science:
- Oncology
- Medical Genetics
Background:
- Advances in understanding molecular pathways and large-scale clinical trials are transforming lung cancer treatment.
- The management of metastatic non-squamous non-small cell lung cancer (NSCLC) is evolving rapidly.
Purpose of the Study:
- To present a simplified treatment algorithm for metastatic non-squamous NSCLC.
- To guide clinicians in the personalized management of advanced lung cancer.
Main Methods:
- Review of recent molecular pathway research in NSCLC.
- Analysis of outcomes from major clinical trials in metastatic lung cancer.
Main Results:
- Personalized and more efficacious treatment strategies are emerging.
- Increased survival rates are observed in specific patient cohorts.
Conclusions:
- A simplified algorithm can aid in the effective management of metastatic non-squamous NSCLC.
- Personalized medicine approaches are improving patient prognosis.

